|
20 |
[2019.01.29] CUBEBIO signs a contract with a China-based large asset management company with regards to NASDAQ listings
|
2019-07-23 |
14,582 |
|
19 |
[2019.01.08] CUBEBIO is awarded the Korean Patent Grand Prize
|
2019-07-23 |
13,855 |
|
18 |
[2019.01.03] Identifying existence of tumor cells at an early stage through the analysis of urine
|
2019-07-23 |
13,030 |
|
17 |
[2018.12.27] CUBEBIO signs a strategic cooperation agreement for IPO in Hong Kong
|
2019-07-23 |
14,009 |
|
16 |
[2018.12.24] CUBEBIO signs a contract with a law firm, JIPYONG, and others for consultation about Asian market entry and listing
|
2019-07-23 |
13,125 |
|
15 |
[2018.10.10] CUBEBIO advances into the global market through overseas Chinese networks.
|
2019-07-23 |
15,348 |
|
14 |
[2018.08.20] CUBEBIO, a cancer diagnostic kit production enterprise, prepares to enter the domestic cancer diagnostics market
|
2019-07-23 |
13,359 |
|
13 |
[2018.01.08] CUBEBIO enters the Australian IVD market... "Diversifying into global markets"
|
2019-07-23 |
15,850 |
|
12 |
[2017.12.28] CUBEBIO signs a contract with a Chinese biomedical company for CDFA registration
|
2019-07-23 |
13,288 |
|
11 |
[2017.12.13] CUBEBIO agrees on a strategic alliance with Greencross MS in relation to its "Purine Metabolite Colorimetric Assay Kit"
|
2019-07-23 |
16,011 |
